Descriptor English: | CD4 Immunoadhesins | ||||||
Descriptor Spanish: |
Inmunoadhesinas CD4
| ||||||
Descriptor Portuguese: | Imunoadesinas CD4 | ||||||
Descriptor French: | Immunoadhésines CD4 | ||||||
Entry term(s): |
CD4 IgG CD4-IgG Immunoadhesins, CD4 |
||||||
Tree number(s): |
D09.400.430.890.200.230 D12.644.541.500.697.249 D12.776.124.486.485.538.500.249 D12.776.124.486.485.680.697.249 D12.776.124.790.651.538.500.249 D12.776.124.790.651.680.660.249 D12.776.377.715.548.538.500.249 D12.776.377.715.548.680.660.249 D12.776.395.550.200.230 D12.776.543.550.200.230 D12.776.828.300.200 D23.050.301.350.230 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016860 | ||||||
Scope note: | Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Pharm Action: |
Immunologic Factors |
||||||
Previous Indexing: |
Antigens, CD (1990-1991) Antigens, Differentiation, T-Lymphocyte (1989) IgG (1989-1991) |
||||||
Public MeSH Note: | 92; CD4 IMMUNOADHESIN (NM) was indexed under IGG & ANTIGENS, CD & ANTIBODIES, ANTI-IDIOTYPIC 1990-91 and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989. |
||||||
Online Note: | use CD4 IMMUNOADHESINS (NM) to search CD4 IMMUNOADHESIN (NM) 1989-91 |
||||||
History Note: | 92; was CD4 IMMUNOADHESIN (NM) 1989-91 |
||||||
DeCS ID: | 30208 | ||||||
Unique ID: | D016860 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1992/01/01 | ||||||
Date of Entry: | 1991/07/12 | ||||||
Revision Date: | 2010/06/25 |
CD4 Immunoadhesins
- Preferred
CD4-IgG
- Narrower
Concept UI |
M0025662 |
Scope note | Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin. |
Preferred term | CD4 Immunoadhesins |
Entry term(s) |
Immunoadhesins, CD4 |
Concept UI |
M0025663 |
Preferred term | CD4-IgG |
Entry term(s) |
CD4 IgG |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey